Item 5. Other Information
Item 5. Other Information.
Insider Trading Arrangements and Policies
No director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the Company adopted or terminated any Rule 10b5-1 trading arrangement or any non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K) during the quarter ended June 30, 2026 .
45
Table of Content
Item 6. Exhibits.
(a) Exhibits
3.1 – Amended and Restated Articles of Incorporation (as amended through July 24, 2019). Incorporated by reference to Exhibit 3.1 as filed by the Registrant with its quarterly report on Form 10-Q filed on August 1, 2019.
3.2 – Amended and Restated By-laws (effective December 19, 2022). Incorporated by reference to Exhibit 3.1 as filed by the Registrant with its current report on Form 8-K on December 20, 2022.
10.1 – Separation Agreement and General Release by and between Quaker Chemical Corporation and Anna Ransley, dated April 21, 2026.*†
10.2 – Amendment No. 4, dated as of April 10, 2026, to the Credit Agreement, dated as of August 1, 2019, as amended. Incorporated by reference to Exhibit 10.5 as filed by the Registrant with Form 8-K filed on April 14, 2026.
31.1
– Certification of Chief Executive Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.*
31.2
– Certification of Chief Financial Officer of the Company pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.*
32.1
– Certification of Chief Executive Officer of the Company Pursuant to 18 U.S. C. Section 1350.**
32.2
– Certification of Chief Financial Officer of the Company Pursuant to 18 U.S. C. Section 1350.**
101.INS
– Inline XBRL Instance Document*
101.SCH
– Inline XBRL Taxonomy Schema Document*
101.CAL
– Inline XBRL Taxonomy Calculation Linkbase Document*
101.DEF
– Inline XBRL Taxonomy Definition Linkbase Document*
101.LAB
– Inline XBRL Taxonomy Label Linkbase Document*
101.PRE
– Inline XBRL Taxonomy Presentation Linkbase Document*
104
– Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS)*
* Filed herewith.
** Furnished herewith.
† Management contract or compensatory plan.
*********
46
Table of Content
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
QUAKER CHEMICAL CORPORATION
(Registrant)
/s/ Thomas Coler
Date: July 30, 2026
Thomas Coler, Executive Vice President, Chief Financial Officer and Principal Accounting Officer (officer duly authorized on behalf of, and principal financial officer of, the Registrant)
47
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.